Calamia, V 840 Cantó, E 1801 Carter, R 1652 Ceponis, A 1618 Calaza, M 1076, 1078 Cantor, RM 1584, 1595 Carter, S 1980 Ceribelli, A 501, 735, 1639 aBSTRACT author Index Calcagno, G 1155, 1685, 1706, 2033, 2202 Calderón, J 2070 Calderone, M 1682 Calich, AL 481, 2078, 2204 Caliz, R 1078 Callahan, LF 690, 691, 1077, 1460, 1461, 1462, 1463, 2071, 2140, 2141 Callen, J 920 Callon, K 881, 1983 Calmon Hamaty, F 1527 Calvo, E 552 Calvo, I 1434 Calvo, J 1888 Calvo-Alen, J 1296, 1871 Camacho, EM 779 Camargo, LM 628 Camargo, TM 1458 Cambi, A 844 Cambon-Thomsen, A 2218 Cambridge, G 739, 743 Caminade, A-M 281 Camoin, L 834 Campana, C 540 Campanini, M 2201 Campbell, PL 1504, 1721 Campbell, RT 692 Campillo, S 1408, 1673, 1691, 2017 Campo, E 1280 Campos, LM 224, 1437 Camps, MT 824, 1888 Camps, S 2041 Can, G 544, 666, 1282, 1283 Can, M 1133, 1208, 1803 Canadian Scleroderma Research Group (CSRG) 1225, 1347, 1348, 2247 Candelieri, A 558, 1962 Canestri, S 355, 744 Cañete, J 20, 538, 543, 1070, 1078, 1449 Canhao, H 1684 CANIOS 1000 Canadian Faces <strong>of</strong> Lupus Investigators 1850 Canizar, M 1562 Cann, J 2191 Canning, C 339, 1066 Cannon, GW 304, 397, 970, 1099, 1792 Cano, C 1754 Cantaert, T 753, 1449, 1977 Cantagrel, A 281, 400, 1088, 1790, 1893, 1894, 2218 Cantarini, L 837 Cantini, F 528, 1652, 1952 Cantrell, RA 52 Canzoni, M 547 Cao, J 1513 Cao, Q 438, 2191 Caorsi, R 657, 1685, 1706 Capacci, A 1239 Capannini, S 222, 1155, 2033, 2202 Caparbo, VF 1546 Capellino, S 1089 Capelozzi, VL 605, 887 Capini, C 1116 Caplan, L 62, 397, 970, 1099, 1395, 1792 Caplice, N 22, 1726 Capone, M 246 Caporali, R 623, 1397 Caputo, R 240, 1436 Caramaschi, P 580 Caramez, B 369 Carassiti, D 430 Carbonell, J 975 Carcamo, WC 1639 Carcelain, G 376 Cardiel-Rios, M 1013 Cardoso-Oliveira, J 356 Carette, S 2198 Carey, JJ 817, 818, 989, 2111, 2112 Carey, T 1575 Caricchio, R 422, 439 Carlos, F 767 Carmona, L 516, 986, 1657 Carneiro-Sampaio, M 260 Caroli, F 657 Caron, J 1497 Carotti, M 1635, 1746, 1787 Carpenter, DM 1326 Carpenter, EL 708 Carpi, F 1582 Carpintero, M 852 Carr, J 203, 1168 CARRA Lupus Disease-Specific Group 1702 Carrat, F 2131 Carreira, P 824, 1171, 2214 Carrera-Marin, AL 1361 Carreño, L 1276 Carson, CW 1606 Carsons, SE 1072, 1311, 1896 Carta, S 657 Carter, C 51, 76, 1542 Carter, E 869 Carter, JD 44, 696, 1647 Carter, MJ 168 Cartin-Ceba, R 680 Cartwright, R 895, 1425, 1435 Carty, A 545, 556 Carulli, J 1753, 1782 Caruso, A 1302, 2044 Carvalho, J 513, 539, 2078, 2204 Carvalho, MS 927 Carvalho-Pinto, C 1732 Carvello, F 18 Casali, M 1290 Casalla, L 50 Casanova, A 598, 1004 Casas, N 1811 Casciola-Rosen, L 487 Casey, VA 1327, 1328, 1331 Cash, TF 1880 Caspi, D 697, 1159 Cassarà, E 528, 1952 Cassidy, C 1234 Cassidy, EA 913, 925, 929, 930 Castañeda, S 1229, 1301, 1505 Castelar-Pinheiro, G 2262 Castelino, FV 606 Castell, E 210 Castellvi, I 824 Castillo-Gallego, C 1967 Castrejón, I 990, 1857 Castro, C 914 Catalán Pellet, A 50 Catanoso, MG 2044 Catanozi, S 887 Catapano, F 678 CATCH Investigators 300, 343, 659 CATCH Scientific Advisory Committee 396 Cathebras, P 2042 Catrina, AI 394 Cattalini, M 1436, 1706 Cattogio, L 50 Cauli, A 532 Cavalcanti, F 1137 Cavalli, L 222 Cavazza, A 2044 Cavet, G 1030, 1496, 1606, 1753, 1782 Ceccato, F 50 Ceccherini, I 657, 1706 Cecilia, G 902 Cefle, A 822 Celik, D 2061 Celis, R 20 Cellucci, T 2107 Cemerski, S 1350 Centola, M 1030, 1496, 1606, 1753, 1782 Cervera, R 451, 452, 1172, 1398, 1848 Cha, H-S 366, 372, 1297 Cha, S 2174 Chabane, N 1489 Chae, J 1523 Chafey, P 834 Chai, A 403 Chaib, A 2035 Chaiban, R 215 Chaisson, C 1362, 1366 Chaisson, RE 908 Chaki, H 280, 1467 Chakravarty, EF 325, 401, 991, 1043, 1960 Chakravarty, K 664 Chalès, G 2261 Chambers, C 325, 1043, 2210 Chami, H 976 Chams-Davatchi, C 1289 Chan, E 501, 600, 735, 1639 Chan, J 735, 1639 Chan, PT 467, 773, 1667 Chan, W 1060, 2089 Chandra, P 1083, 1740, 1764, 2116 Chandran, V 521, 530, 536, 783, 1928, 1932, 1936, 1954, 1956, 1966, 1974, 1975, 1979, 1984, 2273 Chang, AH 189, 202, 2056 Chang, BY 286 Chang, D 58, 1583, 1595 Chang, H 573, 1003, 2061 Chang, J 692, 1571 Chang, N-H 424, 425 Chang, RW 1558, 2096 Chang, S-K 1388 Chang, X 1978 Chang, Y 71 Chapelle, D 260, 1698 Chapman, HA 609 Chapman, P 417 Chapurlat, R 964, 969, 2157 Charis, P 621 Charles, J 1218 Charles-Schoeman, C 299, 471, 933, 1058 Charlotte, F 1646, 1651 Charlton-Menys, V 1067 Charnock, B 690, 2141 Charrier, C 29 Charuel, J-L 915 Chary-Valckenaere, I 551, 768 Chary-Valkenaere, I 1931 Chatelus, E 1237 320 2010 Program Book
Chatham, WW 457, 1146, 1454, 1457, 1668 Chatterjee, S 564, 574, 592 Chaturvedi, S 1551 Chatzidionysiou, K 55, 410, 418, 1807 Chatzidionysou, K 1802 Chaudhari, S 1789 Chaudhary, P 562 Chaudhry, A 678 Chauhan, A 263, 846, 1262, 1601 Chaussade, S 580 Chaves, I 89 Chavez, M 608 Chavez, R 248 Chavez Chiang, N 1055 Chavez-Chiang, N 947, 1567, 1626, 2225 Checa, AE 885 CHECK Group 184 Chédeville, G 236, 1674 Chefo, S 165 Chemel, M 29 Chen, C 1362, 1366 Chen, D 1080, 1127, 1804 Chen, G 1270 Chen, H 570 Chen, J 129, 2088 Chen, K 1151 Chen, L 299, 304, 404, 721, 722, 1077, 1117, 1639, 1643, 2084, 2103 Chen, M 336, 1186, 1734, 1769 Chen, N 65, 557, 644, 760 Chen, PP 8 Chen, Q 432 Chen, R 52, 1799 Chen, W 286, 805, 1598, 1779, 2241 Chen, X 562 Chen, Y 242, 243, 247, 251, 258, 655, 944 Chen-An, P 1500 Cheng, CW 1748, 1777 Cheng, Q 492, 1414 Cheol-Bae, S 2243 Cherascu, BN 970 Chern<strong>of</strong>f, D 1753, 1782 Chetcuti Zammit, S 172 Cheung, AM 1156 Cheung, FC 1748, 1777 Cheung, Y 429, 2190 Chevrant-Breton, J 2238 Chevreul, K 781 Chhana, A 881 Chiarelli, P 888 Chiari, A 2132 Chiarolanza, I 1302, 2044 Chiba, A 896, 2232 Chibnik, LB 1082, 1588 Chiesa, S 657 Chifflot, H 1237 Chighizola, C 590 Childhood Myositis Heterogeneity Study Group 1678 Chines, A 979 Chiocchia, G 1087, 1413, 1981, 2000 Chiodo, L 468 Chiorini, JA 1413, 2178 Chiossone, L 1664 Chiowchanwisawakit, P 667, 1959 Chipping, J 796 Chira, P 1008, 1409, 1673, 1691, 2017 Chitale, S 661, 1763 Chiu, B 696 Chiu, G 849, 1492 Chiu, S 1233 Chiu, YG 521, 1968 Chizzolini, C 1987, 1992 Chmiel, JS 186, 189, 2100 Cho, M 163, 276, 353, 370, 1716 Cho, S-H 602 Cho, Y 505, 2217 Chobaz, V 2151 Choe, J-Y 323, 903 Chohan, S 158, 165 Choi, C 1597, 1714, 1941 Choi, H 72, 523, 720, 879, 1036, 1056, 1363, 1366, 1547, 2067, 2152, 2154, 2155, 2199, 2212, 2213 Choi, IA 387 Choi, J 1246, 2158 Choi, K 1389 Choi, L 75 Choi, S 92, 285, 289, 359, 1209, 1628, 1972 Choi, T-Y 1046, 1443, 2164, 2165, 2166 Chong, K 1131 Chopra, A 66, 1549, 1551, 1640, 1642 Choquette, D 74, 196 Chou, RC 640, 1427 Chow, YW 1278 Choy, E 819, 1766, 1832 Christadoss, ML 1491 Christensen, R 1766 Christensen, TG 1444, 1841 Christiane, AE 1026 Christianson, TJH 2037, 2038 Christodoulou, MI 1897 Christophe, R 2267 Christopher-Stine, L 919 Chu, AD 428 Chu, B-C 338 Chu, ME 58 Chu, SY 1350 Chu, Z 1728 Chu Miow Lin, D 143, 988 Chubinskaya, S 1147 Chun, J 606 Chun, W 885 Chung, C 120, 1034, 1607, 1808, 2123, 2260 Chung, JB 1141 Chung, L 561, 570, 573, 586, 1157, 1213, 1223, 1378 Chung, S 27, 500, 502, 1592, 1602, 2145 Chung, W 257 Chung, Y-J 1589 Church, L 1263 Churchill, D 1645 Ciapetti, A 1746, 1787 Cibere, J 2055 Ciciriello, S 1001, 1009 Cicuttini, F 173, 183, 192, 1383 Cid, M 777, 1276, 1280, 1292, 1294, 1309, 1314, 1637, 1652, 1654 Cifaldi, M 65, 91, 307, 327, 382, 535, 557, 644, 760, 763, 771, 788, 2266 Cifuentes, RA 1048 Cigler, T 898 Cimaz, R 246, 1675, 1872, 240, 1305, 1436 Cimbora, D 493 Cimmino, MA 777, 1637, 1652, 1654 Cinzia, DL 240 Ciregia, F 811 Cistrone, C 1085 Citera, G 324, 50 Ciullini Mannurita, S 261 Cividino, AA 57, 313, 341, 1735 Clair, B 1185, 1196 Clancy, MM 198 Clancy, R 443, 489, 495, 637, 656, 1190, 2231 Clapp, L 2005 Clark, E 747 Clark, P 767 Clark, TB 1382 Clarke, A 214, 445, 448, 454, 476, 731, 1142, 1146, 1170, 1848, 1850, 1877, 2240, 2243 Clarke, J 920 Clary, G 834 Clauw, DJ 100, 650 Clavert, V 1237 Clegg, DO 948 Clemens, P 935 Clements, P 598, 729, 1228, 1232, 2194, 2195, 1205 Clements-Baker, MI 126 Clemessy, M 1991 Clerico, P 1798 Cleveland, C 446 Clifford, B 245, 256 Cliss, A 1325 Close, D 1455, 2085 Clower, J 152, 1713 Clowse, ME 325, 461, 1043, 1154, 1192, 1862 Club Rhumatismes et Inflammation (CRI) 904 Cluzel, P 1287 Co, S 2152 Coates, L 514, 1926, 1929, 2182, 2183 Coca, A 1886 Cocuzza, M 513 Codding, CE 1441 Codreanu, C 405, 1013 Coenen, M 824, 829, 1599, 2004, 2214 C<strong>of</strong>ield, S 299, 1740 C<strong>of</strong>ield, SS 1368, 1779 Coghlan, G 590 Coghlan, JG 727 Cohen, H 812 Cohen, MJ 187 Cohen, P 2009, 2034, 2041, 2043, 2045 Cohen, RB 390 Cohen, SB 403, 1154 Cohen Tervaert, JW 676 Coker, I 1970 Colaci, M 581, 1627 Colato, C 671 Colbert, CJ 186, 189, 202 Colbert, RA 1376 Colin, D 1931 Colin, E 38, 1274 Collaku, L 1962 Collantes, E 525, 986, 2268 Collantes-Estevez, E 1357 Collée, G 1396 Collet, C 1707 Collier, DS 25 Collins, C 1062, 1210 Collins, ES 1105 Collins, JB 1324 Colmegna, I 351, 1336 Colombo, PC 1183 Coman, I 1185 Combe, B 301, 376, 400, 1790, 1946, 2042 Combe, BG 303, 383, 408, 1527, 1732, 1760 2010 Program Book 321 abstract author Index
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS ACCREDITATION . .
- Page 7 and 8:
TABLE OF CONTENTS ACR/ARHP Poster S
- Page 9 and 10:
TABLE OF CONTENTS Systemic Sclerosi
- Page 11 and 12:
the written consent of the ACR is p
- Page 13 and 14:
Shuttle Bus Service See shuttle sig
- Page 15 and 16:
ACR Resource Center Hours: Sunday,
- Page 17 and 18:
ACR Hotels + Map Complimentary shut
- Page 19 and 20:
to the premier meeting in rheumatol
- Page 21 and 22:
ACR Clinical Research Conference c/
- Page 23 and 24:
4:20 PM Germinal Center Reactions A
- Page 25 and 26:
3:30 PM Live Demonstration: Ultraso
- Page 27 and 28:
Upon completion of this session, pa
- Page 29 and 30:
MONDAY, NOVEMBER 8, 2010 ACR/ARHP R
- Page 31 and 32:
B301 Dermatological Manifestations
- Page 33 and 34:
Session Overview: The innate immune
- Page 35 and 36:
Upon completion of this session, pa
- Page 37 and 38:
B308 Inflammatory Eye Disease P/C M
- Page 39 and 40:
and insufficiency • recall source
- Page 41 and 42:
Session Overview: The advent of bio
- Page 43 and 44:
2:45 pm 641. Major Improvements in
- Page 45 and 46:
5 University of Twente and Medisch
- Page 47 and 48:
ACR/ARHP Combined Abstract Session
- Page 49 and 50:
REF 25th Anniversary Celebration 2:
- Page 51 and 52:
5:45 PM 699. Defining Latent and/or
- Page 53 and 54:
Lilian H. D. van Tuyl 8 , Karin Bri
- Page 55 and 56:
ACR REF Special Sessions 4:30 - 6:0
- Page 57 and 58:
REF 5K Run/Walk 6:00 - 8:00 am See
- Page 59 and 60:
• discuss the principles of early
- Page 61 and 62:
ACR Medical Aspects of Rheumatic Di
- Page 63 and 64:
10:00 am 1349. Work as a Daily Chal
- Page 65 and 66:
ACR Plenary Session II: Discovery 2
- Page 67 and 68:
B210 B301 Pediatrics: Periodic Feve
- Page 69 and 70:
Session Overview: As a clinical edu
- Page 71 and 72:
Thomas J. Murphy Ballroom Giant Cel
- Page 73 and 74:
3:45 PM 1367. Serum Urate Levels in
- Page 75 and 76:
A411 Rheumatoid Arthritis - Human E
- Page 77 and 78:
2:45 PM 1405. Development of a Visi
- Page 79 and 80:
4:30 PM Anti-citrullinated Protein
- Page 81 and 82:
of Experimental Orthopedics, Univer
- Page 83 and 84:
5:30 PM 1438. Mortality/Morbidity i
- Page 85 and 86:
5:30 PM 1456. Belimumab, a BLyS-Spe
- Page 87 and 88:
Develly 5 , Bernardo L. F. Fernande
- Page 89 and 90:
7:30 PM Role of IL-1 in Human Artic
- Page 91 and 92:
• compare the prevalence and epid
- Page 93 and 94:
6:45 PM Macrophage Activation Syndr
- Page 95 and 96:
Upon completion of this session, pa
- Page 97 and 98:
Session Overview: This roundtable d
- Page 99 and 100:
B303 Scleroderma: Systemic Sclerosi
- Page 101 and 102:
9:00 - 10:30 am - Poster Hall Morni
- Page 103 and 104:
• describe the role of IL-1 and I
- Page 105 and 106:
Session Overview: For the clinician
- Page 107 and 108:
• identify the aspects for day-to
- Page 109 and 110:
ACR Study Groups 1:00 - 2:00 PM B30
- Page 111 and 112:
Session Overview: Ultrasound and ma
- Page 113 and 114:
Session Overview: Fifty percent of
- Page 115 and 116:
1:20 PM Academic Rheumatology Seth
- Page 117 and 118:
ACR Concurrent Abstract Sessions 2:
- Page 119 and 120:
3:00 PM 2110. Rheumatologists on th
- Page 121 and 122:
2:45 PM 2133. Reasons for Decline i
- Page 123 and 124:
Session Overview: We are witnessing
- Page 125 and 126:
Session Overview: Systemic sclerosi
- Page 127 and 128:
Oaks, CA, 2 Amgen Inc., San Francis
- Page 129 and 130:
5:00 PM 2176. A Role of Autoimmune
- Page 131 and 132:
4:30 PM 2198. Association between V
- Page 133 and 134:
ARHP Concurrent Sessions 4:30 - 6:0
- Page 135 and 136:
THURSDAY, NOVEMBER 11, 2010 ACR/ARH
- Page 137 and 138:
• apply these basic statistics to
- Page 139 and 140:
9:15 AM The ACR/EULAR Definition of
- Page 141 and 142:
Immunology, Oslo University Hospita
- Page 143 and 144:
9:15 AM 2239. Factors Associated wi
- Page 145 and 146:
Upon completion of this session, pa
- Page 147 and 148:
Mikkel Østergaard 6 , Paul Emery 4
- Page 149 and 150:
Ende 4 , 1 Department of Rheumatolo
- Page 151 and 152:
ACR Poster Session A Cytokines, Med
- Page 153 and 154:
ACR Poster Session A 51. Associatio
- Page 155 and 156:
ACR Poster Session A 83. Respirator
- Page 157 and 158:
ACR Poster Session A 121. Bone Dens
- Page 159 and 160:
ACR Poster Session A 142. The Intra
- Page 161 and 162:
ACR Poster Session A 171. Early Pro
- Page 163 and 164:
ACR Poster Session A Pediatric Rheu
- Page 165 and 166:
ACR Poster Session A 233. Prevalenc
- Page 167 and 168:
ACR Poster Session A 266. Subtype S
- Page 169 and 170:
ACR Poster Session A 297. Body Weig
- Page 171 and 172:
ACR Poster Session A 325. Patient R
- Page 173 and 174:
ACR Poster Session A 356. Influence
- Page 175 and 176:
ACR Poster Session A 383. Efficacy
- Page 177 and 178:
ACR Poster Session A 409. Rituximab
- Page 179 and 180:
ACR Poster Session A 441. Recombina
- Page 181 and 182:
ACR Poster Session A 465. Immunoglo
- Page 183 and 184:
ACR Poster Session A 496. IRF8 Alle
- Page 185 and 186:
ACR Poster Session A 521. DC-STAMP
- Page 187 and 188:
ACR Poster Session A 546. Prevalenc
- Page 189 and 190:
ACR Poster Session A 571. Epidemiol
- Page 191 and 192:
ACR Poster Session A 599. Validatio
- Page 193 and 194:
ACR/ARHP Poster Session B Halls B1
- Page 195 and 196:
ACR Poster Session B 767. Economic
- Page 197 and 198:
ACR/ARHP Poster Session B 792. The
- Page 199 and 200:
ACR/ARHP Poster Session B Universit
- Page 201 and 202:
ACR/ARHP Poster Session B 848. Cell
- Page 203 and 204:
ACR/ARHP Poster Session B 886. Scre
- Page 205 and 206:
ACR/ARHP Poster Session B 909. Regu
- Page 207 and 208:
ACR/ARHP Poster Session B 935. The
- Page 209 and 210:
ACR/ARHP Poster Session B 967. Frac
- Page 211 and 212:
ACR Poster Session B 993. Early Exp
- Page 213 and 214:
ACR/ARHP Poster Session B 1022. Com
- Page 215 and 216:
ACR/ARHP Poster Session B 1055. Son
- Page 217 and 218:
ACR Poster Session B 1084. Gene Exp
- Page 219 and 220:
ACR/ARHP Poster Session B 1111. Inc
- Page 221 and 222:
ACR Poster Session B hiroshima Memo
- Page 223 and 224:
ACR/ARHP Poster Session B 1166. Pre
- Page 225 and 226:
ACR/ARHP Poster Session B 1199. Typ
- Page 227 and 228:
ACR/ARHP Poster Session B 1225. Phy
- Page 229 and 230:
ACR/ARHP Poster Session B 1262. Lat
- Page 231 and 232:
ACR/ARHP Poster Session B 1294. End
- Page 233 and 234:
ACR/ARHP Poster Session B 1321. Cha
- Page 235 and 236:
ACR/ARHP Poster Session C Halls B1
- Page 237 and 238:
ACR/ARHP Poster Session C 1495. S10
- Page 239 and 240:
ACR/ARHP Poster Session C 1524. Inc
- Page 241 and 242:
ACR/ARHP Poster Session C 1555. Pro
- Page 243 and 244:
ACR/ARHP Poster Session C 1583. Ass
- Page 245 and 246:
ACR/ARHP Poster Session C 1596. Gen
- Page 247 and 248:
ACR/ARHP Poster Session C 1622. Flu
- Page 249 and 250:
ACR/ARHP Poster Session C Miscellan
- Page 251 and 252:
ACR/ARHP Poster Session C L. Woodwa
- Page 253 and 254:
ACR/ARHP Poster Session C 1692. Res
- Page 255 and 256:
ACR/ARHP Poster Session C 1719. Los
- Page 257 and 258:
ACR/ARHP Poster Session C 1749. Con
- Page 259 and 260:
ACR/ARHP Poster Session C 1780. Tow
- Page 261 and 262:
ACR/ARHP Poster Session C 1804. Eff
- Page 263 and 264:
ACR/ARHP Poster Session C Immunolog
- Page 265 and 266:
ACR/ARHP Poster Session C 2 Departm
- Page 267 and 268:
ACR/ARHP Poster Session C CA, 29 Un
- Page 269 and 270:
ACR/ARHP Poster Session C 1900. IL-
- Page 271 and 272: ACR/ARHP Poster Session C 1930. Cor
- Page 273 and 274: ACR/ARHP Poster Session C 1958. The
- Page 275 and 276: ACR/ARHP Poster Session C 1988. Cha
- Page 277 and 278: ACR/ARHP Poster Session C 2015. CpG
- Page 279 and 280: ACR/ARHP Poster Session C 2038. Pri
- Page 281 and 282: ACR/ARHP Poster Session C 2070. Ass
- Page 283 and 284: REF Industry Roundtable-supported S
- Page 285 and 286: REF Industry Roundtable-supported S
- Page 287 and 288: INDUSTRY-SUPPORTED POST-CONFERENCE
- Page 289 and 290: 2010 ACR/ARHP Annual Meeting Leader
- Page 291 and 292: 2010 ACR/ARHP Annual Meeting Leader
- Page 293 and 294: FLOOR PLANS 2010 Program Book 291
- Page 295 and 296: VISIT THE EXHIBIT HALL New and inno
- Page 297 and 298: EXHIBITORS La Lettre Du Rhumatologu
- Page 299 and 300: ACKNOWLEDGEMENTS The ACR, the ARHP
- Page 301 and 302: ACR/ARHP/REF STAFF LISTING Administ
- Page 303 and 304: A Ahmed, Rafi, PhD T cell Memory .
- Page 305 and 306: Cooper, Max D, MD Introduction . .
- Page 307 and 308: Gerlag, Danielle Marie, MD, PhD The
- Page 309 and 310: Physical Examination Skills for Imp
- Page 311 and 312: Meroni, Pierluigi, MD Autoantibodie
- Page 313 and 314: Rogers, Joan C, PhD, OTR/ L Underst
- Page 315 and 316: Terkeltaub, Robert, MD Crystallizin
- Page 317 and 318: A Aarden, L 1825 Aarrass, S 1519, 1
- Page 319 and 320: Bakker, AAB 1095 Barendregt, B 753
- Page 321: Boutin-Le Thi Huong, D 478 Bout-Tab
- Page 325 and 326: Daudon, M 875 Daugas, E 2009 Davatc
- Page 327 and 328: Ehst, B 758 Eicher, JL 688 Eisen, S
- Page 329 and 330: Gabay, OH 1484 Gaber, T 630, 1418 G
- Page 331 and 332: Guan, M 965 Guañabens, N 975 Gudbj
- Page 333 and 334: Homme, CL 730 Honda, E 434 Hong, JY
- Page 335 and 336: Kambayashi, T 1354 Kamdar, AA 1160
- Page 337 and 338: Kuller, LH 71 Kumabe, M 1164 Kumaga
- Page 339 and 340: Looney, C 941 Looney, MR 609 Looney
- Page 341 and 342: McCarthy, GM 1109, 1306, 1426 McCau
- Page 343 and 344: Myouzen, K 1577 Mysiw, WJ 2096 Mysl
- Page 345 and 346: Pans, M 1834 Parra, ER 605, 887 Ped
- Page 347 and 348: Radka, S 1174 Radner, H 296, 1745 R
- Page 349 and 350: Sack, KE 1898 Sacli, SF 1312 Saddic
- Page 351 and 352: 1463, 2071, 2140, 2141 Singh, K 212
- Page 353 and 354: Takahata, M 1492 Takasaki, Y 1731 T
- Page 355 and 356: 636 van Dongen, CJJ 90 Van Doornum,
- Page 357 and 358: Witte, T 824, 1578, 1579, 2214 Witt
- Page 359 and 360: A α-galactosylceramide 505 A2A kno
- Page 361 and 362: Behcet’s syndrome 1284, 1288, 129
- Page 363 and 364: cost-utility 759, 1539 couples 1324
- Page 365 and 366: fibroblast like synoviocyte 27 fibr
- Page 367 and 368: impact 1063, 1325 inactive disease
- Page 369 and 370: methylation 826, 1253, 1489 methylt
- Page 371 and 372: 233, 234, 240, 243, 252, 262, 268,
- Page 373 and 374:
1599, 1600, 1603, 1605, 1606, 1609,
- Page 375 and 376:
1226, 1227, 1229, 1230, 1231, 1233,
- Page 377 and 378:
Abelson, Abby Goulder, MD Education
- Page 379 and 380:
Massarotti, Elena M, MD Systemic Lu
- Page 381 and 382:
ACR Annual Meeting fellowS-in-train
- Page 383 and 384:
NOTES 2010 Program Book 381
- Page 385 and 386:
Enbrel ® (etanercept) Brief Summar
- Page 387 and 388:
Prescription Enbrel ® (etanercept)
Change language